{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:46:07Z","timestamp":1792539967185,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"vor","delay-in-days":383,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM133041"],"award-info":[{"award-number":["GM133041"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Chemical Biology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.chembiol.2020.08.008","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T10:43:04Z","timestamp":1598524984000},"page":"1383-1395.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Mechanistic Studies of the Multiple Myeloma and Melanoma Cell-Selective Toxicity of the Rpn13-Binding Peptoid KDT-11"],"prefix":"10.1016","volume":"27","author":[{"given":"Paige","family":"Dickson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7594-5952","authenticated-orcid":false,"given":"Scott","family":"Simanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Maina","family":"Ngundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kodadek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2020.08.008_bib1","doi-asserted-by":"crossref","first-page":"e13654","DOI":"10.1371\/journal.pone.0013654","article-title":"Regulators of the proteasome pathway, Uch37 and Rpn13, play distinct roles in mouse development","volume":"5","author":"Al-Shami","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.chembiol.2020.08.008_bib2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ccr.2013.11.001","article-title":"A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13\/ADRM1 as a therapy for cancer","volume":"24","author":"Anchoori","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.chembiol.2020.08.008_bib3","first-page":"531","article-title":"Knockdown of the novel proteasome subunit Adrm1 located on the 20q13 amplicon inhibits colorectal cancer migration, survivability and tumorigenicity","volume":"21","author":"Chen","year":"2009","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.chembiol.2020.08.008_bib4","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/nm.2536","article-title":"Inhibition of proteasome deubiquitinating activity as a new cancer therapy","volume":"17","author":"D'Arcy","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.chembiol.2020.08.008_bib5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pharmthera.2014.11.002","article-title":"Deubiquitinase inhibition as a cancer therapeutic strategy","volume":"147","author":"D'Arcy","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.chembiol.2020.08.008_bib6","doi-asserted-by":"crossref","first-page":"22123","DOI":"10.1074\/jbc.274.32.22123","article-title":"The proteasome, a novel protease regulated by multiple mechanisms","volume":"274","author":"DeMartino","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2020.08.008_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2020.08.007","article-title":"Physical and functional analysis of the putative Rpn13 inhibitor RA190","author":"Dickson","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.chembiol.2020.08.008_bib8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ab.2018.04.018","article-title":"A fluorescence polarization-based competition assay for measuring interactions between unlabeled ubiquitin chains and UCH37\u2217RPN13","volume":"550","author":"Du","year":"2018","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.chembiol.2020.08.008_bib9","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.3390\/ijms14023094","article-title":"Amplification target ADRM1: role as an oncogene and therapeutic target for ovarian cancer","volume":"14","author":"Fejzo","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.chembiol.2020.08.008_bib10","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/gcc.20592","article-title":"Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target","volume":"47","author":"Fejzo","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.chembiol.2020.08.008_bib11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/gcc.20868","article-title":"Knockdown of ovarian cancer amplification target ADRM1 leads to downregulation of GIPC1 and upregulation of RECK","volume":"50","author":"Fejzo","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.chembiol.2020.08.008_bib12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/349132a0","article-title":"Cyclin is degraded by the ubiquitin pathway","volume":"349","author":"Glotzer","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2020.08.008_bib13","first-page":"335","article-title":"Characterization of a novel myeloma cell line, MM.1","volume":"113","author":"Goldman-Leikin","year":"1989","journal-title":"J.\u00a0Lab. Clin. Med."},{"key":"10.1016\/j.chembiol.2020.08.008_bib14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/cbic.200400313","article-title":"Molecular machines for protein degradation","volume":"6","author":"Groll","year":"2005","journal-title":"ChemBioChem"},{"key":"10.1016\/j.chembiol.2020.08.008_bib15","doi-asserted-by":"crossref","first-page":"e1005401","DOI":"10.1371\/journal.pgen.1005401","article-title":"Redundant roles of Rpn10 and Rpn13 in recognition of ubiquitinated proteins and cellular homeostasis","volume":"11","author":"Hamazaki","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.chembiol.2020.08.008_bib16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","article-title":"The ubiquitin system","volume":"67","author":"Hershko","year":"1998","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.chembiol.2020.08.008_bib17","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.2217\/fon.14.30","article-title":"Efficacy of therapy with bortezomib in solid tumors: a review based on 32 clinical trials","volume":"10","author":"Huang","year":"2014","journal-title":"Future Oncol."},{"key":"10.1016\/j.chembiol.2020.08.008_bib18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature06926","article-title":"Proteasome subunit Rpn13 is a novel ubiquitin receptor","volume":"453","author":"Husnjak","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2020.08.008_bib19","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10585-014-9663-4","article-title":"ADRM1 gene amplification is a candidate driver for metastatic gastric cancers","volume":"31","author":"Jang","year":"2014","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.chembiol.2020.08.008_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13048-017-0347-y","article-title":"Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinoma","volume":"10","author":"Jiang","year":"2017","journal-title":"J.\u00a0Ovarian Res."},{"key":"10.1016\/j.chembiol.2020.08.008_bib21","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/cr.2017.41","article-title":"Self-inflicted DNA double-strand breaks sustain tumorigenicity and stemness of cancer cells","volume":"27","author":"Liu","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.chembiol.2020.08.008_bib35","doi-asserted-by":"crossref","first-page":"e0140518","DOI":"10.1371\/journal.pone.0140518","article-title":"A high affinity hRpn2-derived peptide that displaces human Rpn13 from proteasome in 293T cells","volume":"10","author":"Lu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.chembiol.2020.08.008_bib22","doi-asserted-by":"crossref","first-page":"15540","DOI":"10.1038\/ncomms15540","article-title":"Structure of the Rpn13-Rpn2 complex provides insights for Rpn13 and Uch37 as anticancer targets","volume":"8","author":"Lu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2020.08.008_bib23","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ncb3028","article-title":"Systematic characterization of deubiquitylating enzymes for roles in maintaining genome integrity","volume":"16","author":"Nishi","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.chembiol.2020.08.008_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mayocp.2015.11.007","article-title":"Multiple myeloma: diagnosis and treatment","volume":"91","author":"Rajkumar","year":"2016","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.chembiol.2020.08.008_bib25","doi-asserted-by":"crossref","first-page":"8773","DOI":"10.1074\/jbc.M115.694588","article-title":"The proteasome ubiquitin receptor hRpn13 and its interacting deubiquitinating enzyme Uch37 are required for proper cell cycle progression","volume":"291","author":"Randles","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2020.08.008_bib26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev.biochem.78.082307.091526","article-title":"Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes","volume":"78","author":"Reyes-Turcu","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.chembiol.2020.08.008_bib27","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000381658","article-title":"Is ADRM1 a good target for cancer therapy?","volume":"134","author":"Shenoy","year":"2015","journal-title":"Acta Haematol."},{"key":"10.1016\/j.chembiol.2020.08.008_bib28","doi-asserted-by":"crossref","first-page":"13886","DOI":"10.1074\/jbc.274.20.13886","article-title":"Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing","volume":"274","author":"Shirane","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2020.08.008_bib29","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10577-010-9179-y","article-title":"Chromosomes and cancer cells","volume":"19","author":"Thompson","year":"2011","journal-title":"Chromosome Res."},{"key":"10.1016\/j.chembiol.2020.08.008_bib30","doi-asserted-by":"crossref","first-page":"6312","DOI":"10.1021\/jacs.5b02069","article-title":"A reversible and highly selective inhibitor of the proteasomal ubiquitin receptor rpn13 is toxic to multiple myeloma cells","volume":"137","author":"Trader","year":"2015","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2020.08.008_bib31","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.molcel.2015.01.016","article-title":"Structural basis for the activation and inhibition of the UCH37 deubiquitylase","volume":"57","author":"VanderLinden","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.chembiol.2020.08.008_bib32","doi-asserted-by":"crossref","first-page":"9493","DOI":"10.1074\/jbc.M117.785287","article-title":"Structure and energetics of pairwise interactions between proteasome subunits RPN2, RPN13, and ubiquitin clarify a substrate recruitment mechanism","volume":"292","author":"VanderLinden","year":"2017","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2020.08.008_bib33","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/ncb1460","article-title":"Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1","volume":"8","author":"Yao","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.chembiol.2020.08.008_bib34","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev-biophys-070816-033719","article-title":"Recognition of client proteins by the proteasome","volume":"46","author":"Yu","year":"2017","journal-title":"Annu. Rev. Biophys."}],"container-title":["Cell Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945620303056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945620303056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:50:05Z","timestamp":1778889005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451945620303056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S2451945620303056"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2020.08.008","relation":{},"ISSN":["2451-9456"],"issn-type":[{"value":"2451-9456","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic Studies of the Multiple Myeloma and Melanoma Cell-Selective Toxicity of the Rpn13-Binding Peptoid KDT-11","name":"articletitle","label":"Article Title"},{"value":"Cell Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2020.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2020.08.007","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}